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Abstract
Background: Mental health outcome measures are used to monitor the quality and effectiveness of mental health
services. There is also a growing expectation for implementation of routine measurement and measures being used
by clinicians as a feedback monitoring system to improve client outcomes. The recent focus in Australia and elsewhere
targeting mental health services to young people aged 12–25 years has meant that outcome measures relevant to
this age range are now needed. This is a shift from the traditional divide of child and adolescent services versus adult
services with a transitioning age at 18 years. This systematic review is the first to examine mental health outcome
measures that are appropriate for the 12 to 25 year age range.
Methods: MEDLINE and PsychINFO databases were systematically searched to identify studies using mental health
outcome measures with young people aged 12 to 25 years. The search strategy complied with the relevant sections
of the PRISMA statement.
Results: A total of 184 published articles were identified, covering 29 different outcome measures. The measures were
organised into domains that consisted of eight measures of cognition and emotion, nine functioning measures, six
quality of life measures, and six multidimensional mental health measures. No measures were designed specifically for
young people aged 12 to 25 years and only two had been used by clinicians as a feedback monitoring system. Five
measures had been used across the whole 12 to 25 year age range, in a range of mental health settings and were
deemed most appropriate for this age group.
Conclusions: With changes to mental health service systems that increasingly focus on early intervention in
adolescence and young adulthood, there is a need for outcome measures designed specifically for those aged 12 to
25 years. In particular, multidimensional measures that are clinically meaningful need to be developed to ensure quality
and effectiveness in youth mental health. Additionally, outcome measures can be clinically useful when designed to be
used within routine feedback monitoring systems.
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Background
An outcome measure in mental health care can be
defined as a tool used to measure the effect on a per-
son’s mental health as a result of health care interven-
tion, plus any additional extra-therapeutic influences [1].
Specifically, outcome measures are quantitative indica-
tors used at two or more points in time: baseline, post-
intervention, discharge, or follow-ups [2, 3]. Routine
outcome measurement, whereby the same outcome
measure is used frequently at a number of time points,
has been adopted in child and adolescent mental health
services in Australia, New Zealand, Denmark, United
Kingdom and Norway [4]. This push has been driven by
an increasing emphasis on monitoring the quality and
effectiveness of services [5, 6].
Routine outcome measurement reported at the service
level enables decision making around funding of ser-
vices, particularly at a government level where health
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resources are limited and need to be distributed to
achieve the best outcomes [4]. It is also essential as a
component of ongoing service-level quality improve-
ment. Importantly, routine outcome measurement im-
proves clinical practice when it is part of a feedback
monitoring system for clinicians [7]. When mental
health measures are regularly provided to the clinician
they can inform clinical decision making and enable the
clinician to adjust treatment planning accordingly [8]. In
adult mental health services feedback has been shown to
increase accuracy of diagnosis, improve communication
between client and clinician, enhance treatment monitor-
ing, and help clients maintain positive effects for longer
periods [9, 10]. For clients who are not improving or who
are deteriorating during therapy, feedback systems can
help improve outcomes [9]. Emerging research in youth
mental health contexts suggests similar benefits of feed-
back monitoring systems for younger clients [11, 12].
To be useful, mental health outcome measures must
be valid and reliable, sensitive to change, comparable
across relevant client groups and service types, and
meaningful to both clients and clinicians [6]. Fundamen-
tally, outcome measures must be sensitive to change and
be able to clearly convey the magnitude of change
achieved [13]. However, measuring change is complex
and needs to go beyond reporting statistical significance.
Effect sizes and the timescale in which the change is evi-
dent are essential [14]. An increasingly used technique is
calculating a measure of reliable change, which takes
into account the reliability of the measurement instru-
ment and has been proposed to provide a more accurate
standard of meaningful change [15, 16]. Additionally,
estimating clinical significance, which is distinct from
statistical significance, has been recommended in mental
health contexts. Change is clinically significant when a
client moves from the dysfunctional to the functional
range during therapy. This technique is not commonly
used as it requires comparison populations and norms
[17]. These metric are useful, however, as a client can be
considered “recovered” when their outcomes show both
reliable change and clinical significance [16]. Meaningful
changes are also those that are of value and considered
important by the client, family or clinician [18, 19]. Not-
ably, quantifiable change can be different from perceived
change, which means that it is important to determine
outcome measures that are personally meaningful to
clients [20].
Outcome measures need to be comparable over rele-
vant client groups and treatment settings, and help in-
form initial case formulation and client prioritisation
access. Outcome measures are increasingly designed to
measure broad mental health status rather than assess
symptoms associated with the diagnosis of specific men-
tal disorders [21]. Specific measures may be required for
diagnosis, but are not helpful when making comparisons
between cases and services where differences in case
mix exist [22]. Using specific diagnostic measures also
means clinicians need to isolate a particular presenting
problem at baseline to assess subsequent change. This
presents challenges for the common situations when
clients have comorbid mental health issues or their
presenting issues change over the course of therapy
[11, 23]. In contrast, measures of general mental
health can be used in a range of mental health set-
tings with different client characteristics, including
public mental health agencies, private organisations,
schools, and hospitals. Being generically relevant to a
broad range of mental health presentations enables the
measure to cater for clients with no disorder, such as
those accessing prevention mental health programs,
through to those with severe disorder, such as inpatient
hospital clients [24]. It is important to note the role of out-
come measures in epidemiological studies to track natur-
alistic change in non-clinical populations.
To be clinically useful, outcome measures need to be
meaningful to clients and relevant to the areas in which
they have treatment goals. Research with mental health
service consumers shows that many measures are not
particularly relevant to their situations and do not cap-
ture outcomes that are personally meaningful [25].
Determining an outcome measure that is applicable in
both clinical work and service evaluation is challenging
[26]. Mental health is a broad construct that comprises a
number of different measurement domains [27]. These
include measures that cover recovery, cognitive perform-
ance and emotional experience, ability to undertake daily
activities and maintain interpersonal relationships con-
sistent with development stage, and general life satisfac-
tion and wellbeing [1, 28, 29]. Each domain has been
recognised as providing a meaningful aspect of a client’s
mental health status, but may vary in value for clinical
use, service evaluation and epidemiological studies [27].
There is a long history of outcome measures for adult
mental health services and for child and adolescent ser-
vices, including both community-based and inpatient
settings. In Australia, a comprehensive report on out-
come measurement in community settings identified
136 measures, of which 31 were deemed most appropri-
ate and being relevant for children and adolescents,
adults or older persons [29]. The measures incorporate
both client and clinician reporters, and parent reporter
measures were available for children and adolescents
[22]. Historically, outcome measures have either been
targeted towards children and adolescents or adults,
reflecting the traditional demarcations within the mental
health care system [30]. For example, the Health of the
Nation Outcome Scales (HoNOS) has two versions, one
for adults aged 18 to 64 years and a child and adolescent
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version (HoNOSCA) for those aged under 18 years [31].
Outcome measures specific to the youth transition
period of adolescence and young adulthood are urgently
needed due to recent changes in mental health service
delivery specifically targeting this age range [32].
Reorienting mental health services to focus on young
people is supported by understanding that they have the
highest burden of mental illness across the lifespan,
comprising 55 % of the burden of illness for the 15 to
24 year old age group [33]. At least one in four young
people aged 12 to 24 years experiences a mental health
problem in any given year [34]. Research indicates that
75 % of people suffering from a psychiatric disorder in
adulthood experience onset by the age of 24 [35]. Of
particular concern, however, young people are least
likely to access support from mental health care organi-
sations [32]. A systematic review of barriers and facilita-
tors to mental health help-seeking in young people from
qualitative studies identified the major barriers as prob-
lems recognising symptoms, a preference for self-
reliance, and perceived stigma and embarrassment [36].
There is also a pervasive belief among young people that
seeking help does not help [37]. Consequently, ways to
ensure mental health support is effective, and perceived
to be so, are essential to engage young people in services
[38], and this requires being able to demonstrate mean-
ingful outcomes from young people’s mental health
service use [39].
Due to increased vulnerability to mental disorder dur-
ing adolescence and early adulthood, the transition from
child and adolescent to adult mental health services at
the age of 18 years is extremely disruptive to effective
mental health care; it undermines continuity of care at
the time when this needs to be strongest [40]. Early
intervention youth mental health initiatives are strongly
promoted in Australia [41] and gaining momentum in
many other countries [42]. Youth-focused service in-
novations focus on the importance of factors such as
youth participation, shared decision making, and easy
early access. This has led to the development of tools
and supports aimed at engaging young people, such
as age appropriate psychosocial and mental health as-
sessments [43]. New methods of delivering mental
health interventions to young people have also
emerged, which include online and smart phone ap-
plications of counselling, self-help, assessment, and
support groups [44].
Consequently, appropriate outcome measures are now
required that are appropriate to young people’s develop-
mental, social and emotional stages [45, 46]. The current
study comprised a systematic review to identify appro-
priate mental health outcome measures for young people
aged 12 to 25 years. Specifically, the review aimed to
identify outcome measures that could be used for a
broad range of mental health presentations and assessed
mental health through global measures of cognition and
emotion, functioning, quality of life and multidimen-
sional factors (rather than focussed on specific diagnos-
tic symptoms). The review aimed to explore how
outcome measures have been used to track change, in
what populations and settings they have been used, and
whether they have been used as a feedback monitoring
system to clinicians.
Methods
Search strategy
The search was conducted using the MEDLINE and Psy-
chINFO databases, covering studies published since the
inception of each database until the 9th June 2014. The
search terms comprised four categories: young people,
measures, mental health and change (see Table 1). These
were combined using ‘and’ statements and searches were
performed on article titles, abstracts and subjects. Add-
itional studies were identified through hand searching the
references of relevant studies and reviews. The search
methodology and reported findings comply with the rele-
vant sections of the Preferred Reporting Items for System-
atic Reviews and Meta-Analyses (PRISMA) statement
[47]. See Additional file 1 for PRISMA checklist.
Eligibility criteria
The eligibility criteria included articles reporting global
measures of mental health, used with a range of mental
health populations for young people aged 12 to 25 years,
and measuring change over time. Case studies, reviews,
single study specific outcome measures and studies in-
cluding participants with other medical conditions were
excluded. To be included, studies had to:
 be written in English;
 include participants with a mean age in the range
of 12 to 25 years;
 describe an outcome measure used as a general
measure of mental health, including measures of
Table 1 Search terms
Categories Words & phrases
Young person Young, youth*, adolescen*
Measures Measure, assessment, rating, scale,
screen, questionnaire, checklist, tool
Mental health Mental health, mental illness, mental
disorder, emotional problems, top
problems, psychological adjustment,
psychological distress, psychiatric
disorder, well-being, global functioning,
quality of life
Change Change, improve*, progress
*Is a wildcard character that may be used in place of any number of
characters in a search word
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emotion and cognition, functioning, quality of life
and multidimensional mental health;
 report outcome measures tracking change over
at least two measurement time points; and
 be applicable to a general mental health population
or used with a variety of specific mental health
populations (rather than be unique to a particular
mental disorder or condition).
Additionally, the criteria excluded studies:
 of only adult or child participants;
 that were case studies or reviews;
 where participants had conditions related to physical
health, developmental delays, neurological
impairments, intellectual disabilities, learning
disorders, situational stress/trauma and substance or
alcohol dependence; and
 which had an outcome measure that was single
study specific.
Data extraction
Following the database search, duplicates were firstly re-
moved. Titles and abstracts were then screened and irrele-
vant studies removed. Full text articles of studies
identified as possibly relevant for inclusion were then ob-
tained and both authors inspected these against the
eligibility criteria for inclusion. The database search was
extensive, but authors of the published articles were not
contacted to obtain further information to that published.
Additional searching by name of each outcome measure
identified in the review was not conducted as the aim was
to identify outcome measures that met the eligibility
criteria rather than identify every published article on the
identified measures. Figure 1 shows the PRISMA flow
diagram for study inclusion.
Relevant information from each article was entered
into a spreadsheet that included: age, gender, ethni-
city, socioeconomic status, country, diagnosis, sample
size, research design, setting, time of follow-up, re-
porter, measure change magnitude, and use in feed-
back monitoring systems. The articles were then
sorted into groups by the outcome measure(s) identi-
fied in the article. If more than one eligible measure
was reported, the article was included under each
relevant outcome measure group. Lastly, the outcome
measures were categorised according to the major do-
mains of cognition and emotion, functioning, quality
of life or multidimensional.
Results
Search results
The search strategy identified 184 published articles cov-
ering 29 different outcome measures, with many articles
Fig. 1 PRISMA flow diagram
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identifying more than one measure. The key characteris-
tics of each article by type of measure are summarised in
Additional file 2. The outcomes comprised eight mea-
sures of cognition and emotion, nine of functioning, six
that were quality of life, and six multidimensional men-
tal health measures. The GAF, a measure of functioning,
was the most commonly referenced measure overall.
The most referenced measure of cognition and emotion
was the CBCL; for quality of life, it was the SF-36; and
the most referenced multidimensional measure was the
HoNOSCA.
Age range
Figures 2, 3, 4 and 5 show the age range and mean age
for each measure in each article. Of the 29 outcome
measures, 22 were used in at least one study with a sam-
ple that ranged across the age 18 child/adult demarca-
tion point. However, only 11 of these measures were
used in samples that had mean ages in both the 12 to 17
and 18 to 25 year groups. These included the BPRS,
GHQ-12, K10, SCL-90-R, YSR, CGAS, CGI-S, GAF,
SOFAS, SF-36, and WHOQOL-BREF. The YSR and
CGAS were used predominately in the under 18 year
Fig. 2 Age range and mean of cognition and emotion measures
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age range. It is important to note that none of the multi-
dimensional measures were used in samples with mean
ages both above and below 18 years. There were three
measures used with young people below 18 years that
had an adult countermeasure used at follow-up: the YSR
(YASR), CGAS (GAS), and HoNOSCA (HoNOS).
Eight measures were used across the whole 12 to
25 year age range, comprising the BPRS, GHQ-12,
K10, YSR, CGI-S, GAF, SF-36 and WHOQOL-BREF.
The BPRS was predominately used with samples diag-
nosed with psychosis and schizophrenia. The YSR was
slightly modified in one article, with the term ‘kids’
changed to ‘young people’, so that it could be used
across the broader 12 to 25 year age group, rather
than just with those aged under 18 years. The GHQ-
12 was only used in non-clinical samples, and mainly
over longer time periods tracking naturalistic change.
Consequently, there were only five measures deemed
to be suitable for use across the whole 12 to 25 year
age range and applicable to a variety of clinical and
research settings and population groups: K10, CGI-S,
GAF, SF-36 and WHOQOL-BREF.
Fig. 3 Age range and mean of functioning measures
Kwan and Rickwood BMC Psychiatry  (2015) 15:279 Page 6 of 19
Outcome measure reporter
Outcome measures can be reported by the client
(self-report), parents/carers or clinician. The review
identified 13 of the 29 measures as having more than
one reporter. Eight measures were self-report by the
young person, which were the GHQ-12, K10, YSR, YP
CORE, and all quality of life measures except the
KIDSCREEN-52 and WHOQOL-BREF. Eight mea-
sures were clinician reported, comprising the HoNOS
and most measures of functioning. All articles that
referenced the SOFAS did not note the reporter, but
this measure is clinician assessed.
Outcome measures with options for all three re-
porters were the SDQ, SFSS, CGI-I, and Ohio Scales.
Only one of the 13 articles for the CGI-I used all
three reporters, and this study aimed to explore dif-
ferences between reporter types. The CBCL was the
only measure with a teacher report in one article.
This measure also has parent and clinician reporter
versions, and a self-report version, the YSR, in the
Fig. 4 Age range and mean of quality of life measures
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same family of measures and used in a number of the
same studies. The CBCL and YSR were kept distinct,
however, due to the different age ranges they target.
Population groups
Out of the 29 outcomes measures, two were used specif-
ically in non-clinical, community-based samples: the
GHQ-12 and SWLS. The remaining 27 measures were
used with various clinical participant samples, and 10
measures were used in both clinical and non-clinical
samples: the CBCL, K10, SDQ, SCL-90-R, YSR,
KIDSCREEN-52, SF-36, WHOQOL-BREF, BASC-2, and
Y-OQ. It is important to note that all functioning mea-
sures and multidimensional measures, except the BASC-
2 and Y-OQ, were used only in clinical samples.
Intervention types
All outcome measures were used in at least one trial or
treatment interventions. Many also explored naturalistic
change over time in the absence of an intervention, in-
cluding the CBCL, GHQ-12, K10, SCL-90-R, YSR,
KIDSCREEN-52, SF-36, SWLS, and WHOQOL-BREF.
Fig. 5 Age range and mean of multidimensional measures
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The GHQ-12, KIDSCREEN-52, and SWLS were pre-
dominately used to measure naturalistic change. No
measures of functioning or multidimensional mental
health were used to examine naturalistic change.
Change magnitude
The review determined whether the outcome measures
were used to assess change using tests of significance,
effect size, reliable change and clinical significance. All
but one outcome measure (SWLS) reported change
magnitude over time. There were 28 measures that re-
ported tests of significance and 17 included effects sizes.
Outcome measures showing small to medium effect
sizes included the BPRS, CBCL, K10, SCL-90-R, SFSS,
YSR, KIDSCREEN-52, SF-36 and YP CORE. Measures
showing medium to large effect sizes included the SDQ,
CAFAS, CGAS, CGI-S, GAF, EQ-5D, YQOL-R and
HoNOSCA. Effect sizes of small, medium and large were
based on Cohen’s d of 0.2, 0.5, and 0.8, respectively.
Of the five measures identified suitable for use with
the whole 12 to 25 year range, the K10, CGI-S, GAF and
SF-36 reported effect sizes. The K10 was used in one
study involving 36 non-clinical participants comparing
two online coping programs and a control over nine
weeks. There was a significant main effect over time for
all three groups, with a small effect size [48]. The CGI-S
was used with 20 participants for treatment of anxiety,
showing a large effect size over 14 weeks of treatment
[49]. A study used the GAF with 74 psychiatric out-
patient participants with a range of disorders being
treated with a Mindfulness-Based Stress Reduction
(MBSR) program compared to Treatment as Usual
(TAU). After post treatment (8 weeks) and follow-up
(3 months) a large effect size was evident for the MBSR
group compared to a small decline in the TAU group
[50]. Lastly, the SF-36 was used with 63 participants
being treated for first-episode mania, demonstrating
small effect sizes on both mental and physical compo-
nent scores after 6, 12 and 18 months [51].
Only seven of the measures were analysed using a reli-
able change index, which included the SDQ, SCL-90-R,
YSR, CGAS, GAF, Ohio scales, and Y-OQ. The SDQ,
SCL-90-R, and CGAS were used in randomised trials
which showed reliable change index cut-off comparisons
between intervention and control groups. The SDQ,
used in a randomised trial of Acceptance and Commit-
ment Therapy (ACT) compared to TAU, showed a reli-
able improvement for 26 % compared to 0 % at post
treatment, respectively [52]. In a randomised trial
reporting reliable change using the SCL-90-R, MBSR
showed 59 % of participants with no change and 41 %
improved, while TAU showed 10 % worsened, 62 % had
no change and 27 % improved [50]. The CGAS was used
in a study of female Apache American Indians with
depression, to measure outcomes for a cognitive-behaviour
based program versus an education support program. Dif-
ferences in reliable change between the two interventions
were reported at post intervention (8 weeks), 12 weeks,
20 weeks and 32 weeks [53].
Five outcome measures used tests of both clinical sig-
nificance and reliable change; namely, the SCL-90-R,
YSR, GAF, Ohio Scales, and Y-OQ. The GAF was used
in a young adults’ counselling centre with 78 Swedes
aged 16 to 23 years with a range of mental health disor-
ders. A reliable improvement was calculated to be an in-
crease of at least 10 points on the GAF. At post
treatment, with mean length of treatment being
11 months, 52 % of participants showed reliable im-
provement while 48 % showed no change. Additionally,
31 % demonstrated clinically significant improvement
[54]. A study using the Y-OQ in a school-based mental
health treatment program reported both reliable change
and clinical significance to conclude that 45 % of clients
had “recovered” by meeting both criteria [55].
Follow-up time frame
The systematic review extracted follow-up time frames
for the outcome measure studies, and categorised these
as: short-term (0–6 months), medium-term (over
6 months-1 year), and long-term (over 1 year). Many
measures were used across all three time frames. Mea-
sures used only in a short-term time frame included the
SFSS, BASC-2, and Ohio Scales. The CGI-I, CGI-S,
YQOL-R, and Y-OQ were primarily used in short-term
time frames but did have some variation. Two measures
primarily used in a long-term time frame were the
KIDSCREEN-52 and GHQ-12. A small number of stud-
ies reported routine use of outcome measures, whereby
the same measure was used at multiple time points:
SDQ, SFSS, and Y-OQ.
Sample demographics
The outcome measures were all used with a range of
sample demographics, according to gender, ethnicity and
socioeconomic status. All 29 outcome measures were
applied in equivalent ways for males and females; only
one study using the K10 identified a participant that was
transgender.
The majority of studies did not report ethnicity
and, for those that did, there was little consistency.
There were five measures that only reported primarily
Caucasian samples, but no further information on
what this broad category comprised, which were the
VFI, SFSS, EQ-5D, BASC-2, and Ohio Scales.
In most studies, the socioeconomic status of the sam-
ple was not reported. Outcome measures that reported
being used in a lower socioeconomic sample included
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the CBCL, GHQ-12, SDQ, YSR, CGAS, CIS, GAF,
SOFAS, VFI, and SWLS.
Feedback systems
The review identified three outcome measures used rou-
tinely, however only two of these measures were used as
part of a feedback monitoring system, the SDQ and
SFSS. In each case, these measures were used repeatedly
to provide routine feedback to the clinician on the young
person’s outcomes. No functioning, quality of life or
multidimensional measures were used as a feedback
monitoring system.
The SDQ was specifically adapted in one study to be
able to be used routinely in a feedback system. This ses-
sion by session measure (SxS) was used to examine
treatment effects using the feedback monitoring system
during TAU over a year. Participants were recruited
from Child and Adolescent Mental Health Services out-
patient clinics, aged 11 to 19 years with a range of men-
tal health disorders. The young clients and parents
reported the SxS measure, which was fed back to clini-
cians and discussed with the young client. Results
showed statistically significant changes after a year on
the CGAS and young person reported SxS, however, no
statistically significant changes in the HoNOSCA and
parent reported SxS [56].
The SFSS was used in a randomised cluster controlled
trial comparing weekly feedback versus no feedback
monitoring system with young people being treated for a
range of mental health disorders. Participants were re-
cruited through a private health organisation, were aged
11 to 18 years and participated in the study for a mean
time of 16.5 weeks. The SFSS used young person, parent
and clinician reporters. Client participants with clini-
cians who received feedback on the SFSS improved fas-
ter than those with no feedback. Feedback effect sizes
were small, being 0.18, 0.24, and 0.27 for reports from
young people, clinicians, and parents, respectively. There
were stronger effects when clinicians viewed multiple re-
porter sources; that is, from young persons, parents and
clinician [12].
Discussion
This systematic review identified 29 mental health out-
come measures, reported in 184 articles examining
change in mental health status for young people aged
from 12 to 25 years. It is the first review to examine out-
come measures specifically across this age range. Prior
reviews have reflected the traditional mental health ser-
vice system demarcation by focussing on outcome mea-
sures used with either children and adolescents or with
adults [22, 29]. The focus of the review was on general
mental health outcome measures, rather than disorder-
specific symptom measures, consistent with recent
research highlighting the need to measure outcomes
across comorbid conditions, changing presenting prob-
lems, and different client types and settings [22, 29].
Age range appropriate measures
There were eight outcome measures identified as being
used across the whole 12 to 25 year age range. These
were the BPRS, GHQ-12, K10, YSR, CGI-S, GAF, SF-36
and WHOQOL-BREF, but none are developed specific-
ally for this target age range. Three measures are consid-
ered to be less appropriate for general youth mental
health, namely: the BPRS, because it is used primarily
with psychosis; the YSR, as it was specifically designed
for clients under the age of 18 years; and the GHQ-12,
which is mainly used with non-clinical samples to track
naturalistic change. This leaves five measures deemed
suitable for use across the whole 12 to 25 year age range
and applicable to a variety of clinical and research set-
tings and population groups: K10, CGI-S, GAF, SF-36
and WHOQOL-BREF. A discussion of their strengths
and weaknesses follows.
The K10 was developed by Kessler and colleagues as a
measure of non-specific psychological distress. It is a 10-
item self-report measure which asks clients about symp-
toms of anxiety and depression in the past four weeks.
The K10 has been widely used as a measure of mental
health status in population surveys as well as an outcome
measure in primary care settings. It demonstrates strong
validity, excellent reliability and has been shown to be sen-
sitive to change [29]. No studies have examined the feasi-
bility of the K10 as a routine outcome measure; however,
it has been noted as easy to use, brief and is one of the key
outcome measures for the Better Outcomes in Mental
Health Care Initiative in Australia [29]. In the current re-
view, the K10 was shown to be used with clinical and
non-clinical samples, tracking both treatment effects and
naturalistic change. Change in the K10 was reported
mainly with tests of statistical significance and a small
effect size was demonstrated in one study.
The CGI-S is a brief clinician-rated global measure
of current severity of the client’s symptoms and func-
tioning. The CGI-S is one-item asking the clinician,
in their clinical experience, how mentally ill the client
has been over the past week from “normal” to “ex-
tremely ill” [57]. The CGI-S has been shown to be
sensitive to change, showing similar change to the
HoNOS. It has been identified as suitable for routine
use due to its brevity and ease of administration [58].
However, there are questions about its validity and
reliability and efforts have been made to improve its
psychometric properties [59]. In the current review,
the CGI-S was used only with clinical samples, and
change was reported using statistical significance and
effect size, revealing large statistical effects.
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The GAF is a clinician-rated scale giving a measure of
overall psychiatric disturbance integrating three dimen-
sions of functioning: psychological, social and occupa-
tional. It is a single-item measure on a 100-point scale
divided into 10-point intervals [60]. It has shown good
construct and concurrent validity, but questions have
been raised over its content validity. Inter-rater reliability
can be low, particularly in routine clinical use [29]. It is
sensitive to change when correlated with change in the
Positive and Negative Syndrome Scale (PANSS) [61].
The GAF is brief, easy to use and reliability can be
increased with minimal training, which makes it more
acceptable in routine clinical settings [29]. In the current
review, the GAF was the most frequently referenced
measure, was used in only clinical samples, and showed
large effect sizes and both reliable and clinically signifi-
cant change. The GAF was included in the revised third
and fourth editions of the Diagnostic and Statistical
Manual (DSM), but removed from Version 5 in favour
of the World Health Organization Disability Assessment
Schedule 2.0. The DSM-5 Task Force decided that the
GAF was not an adequate assessment of psychiatric
functional impairment due to its lack of conceptual clar-
ity, the need for separate assessment of severity and dis-
ability, questionable psychometrics in routine practice,
and the need for specific training for proper routine
clinical use [62].
The SF-36 is a multipurpose, self-report, short-form
health survey containing 36 items grouped under eight
scales: physical functioning, role limitation due to phys-
ical functioning, bodily pain, general health, vitality,
social functioning, role limitation due to emotional
problems and mental health. The eight scales can be
summed into physical and mental health summary
scores. The SF-36 has been used with a range of mental
disorders and physical diseases, and a variety of treat-
ments. It has been shown to be valid, reliable, sensitive
to change, brief and easy to use [29]. In the current
review, it was the most referenced measure of quality of
life, when including its shorter 12-item version. The SF-
36 was used in both clinical and non-clinical settings,
over short to long-term time frames, and showed small
to medium effect sizes.
The Australian WHOQOL-BREF comprises 26 items
measuring broad domains of physical health, psycho-
logical health, social relationships and environment over
the last two weeks. It has good validity, reliability and
sensitivity to change, however, has been suggested to
be more appropriate for use at a population level
[29]. In the current review, it was used primarily with
clinical samples over short time frames, although one
study used a larger non-clinical sample tracking nat-
uralistic change. The WHOQOL-BREF has both
young people and clinician reporters, however, self-
report is recommended if the client has sufficient
ability to complete the measure.
These five outcome measures were used effectively in
studies of samples spanning the 12 to 25 year age range,
even though they were originally developed for use with
adults. None of these measures has been tested specific-
ally for its clinical utility or psychometric properties for
the youth age range. The current review did not identify
any outcome measures developed specifically for the
adolescent and young adult demographic. While these
five measures seem promising, further tests of psycho-
metrics and clinical utility are needed.
Despite the lack of targeted measures, there were 22
out of 29 outcome measures identified in the review that
were used in at least one study with a sample that
ranged across the 18 years of age mental health service
system demarcation point. These included measures that
were originally developed to be used with young people
only up to the age of 18 years, such as the CBCL, YSR,
and KIDSCREEN-52 [63–65]. This reveals the need for
specifically developed and targeted measures for young
people. There are major developmental changes that
occur for young people from the ages of 12 years,
around the time of the onset of puberty, to 25 years,
which is well into adulthood [66]. It is highly likely that
useful measures for this age range would need some
clearly defined flexibility to accommodate developmental
changes, particularly in areas of psychosocial functioning
such as intimate relationships, education and work.
Type of reporter
Outcome measures can be self-report, clinician report or
reported by relevant others (such as parents or teachers),
and these different perspectives are all important for
treatment [46]. In particular, self-report measures are es-
sential for youth, to recognise their growing maturity
and independence and engage them in their own treat-
ment progress.
The place of parent reports may need further consid-
eration, however, the current review identified very little
use of parent reporters across the 12–25 age range, and
only for children and adolescents [22]. New models of
youth-focused care recognise the critical role of family,
and parent reports may be relevant for clients up to
25 years of age [42], by providing another source of
insight, particularly around changes in behavioural diffi-
culties [67]. Careful attention would, however, need to
be given to consent and confidentiality issues [66, 68].
Tracking change
All the outcome measures identified in this systematic
review were used to track change over time. There were
eight measures used primarily within a six month
period, suggesting they might be more sensitive to
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change in a relatively short time frame. In contrast, the
KIDSCREEN-52 and GHQ-12 were used predominately
in longitudinal population studies. Only three out of 29
outcome measures reported being used routinely used at
multiple time points: SDQ, SFSS, and Y-OQ. Routine
use of outcome measures is a necessity when used as a
feedback monitoring system, and this was demonstrated
in studies using the SDQ and SFSS.
Only seven outcome measures were used to report
reliable change, and only five of these also reported clin-
ically significant change. This is concerning as studies
have shown that reliable and clinically significant are
more clinically meaningful change measures for mental
health research [13]. These methods were designed to
account for measurement error and clinical thresholds,
requiring change to be statistically reliable and demon-
strate movement from a dysfunctional to the functional
population distribution [15]. Using these criteria, indi-
viduals can be classified into the outcome categories of
recovered, improved, unchanged, or deteriorated, which
are meaningful and interpretable categories [16]. How-
ever, it should be noted, that calculations of reliable
change and clinical significance produce more conserva-
tive change results than other approaches [16, 69]. Fur-
ther, in an early intervention context, clinical significance
may not be appropriate as most clients may not present in
the dysfunctional range to start with. In these contexts,
clinical deterioration should be monitored, however, to
determine whether clients change from the functional to
the dysfunctional distribution, indicating need for higher
levels of intervention. More research is needed in this area
to determine optimal change indices for youth outcome
measures.
Routine feedback
There has been an increase in demand for outcome
measures to be used as a feedback monitoring system
for clinicians [8]. Very few outcome measures were iden-
tified in the current systematic review that were used in
this way, and these were designed for children and ado-
lescents under 18 years [70]. The SDQ used young per-
son and parent reporters and this information was fed
back to clinicians to discuss with the young person.
Treatment as usual with SDQ feedback showed statisti-
cally significant change on the CGAS post treatment,
however, the study did not have a comparison group so
it was unknown whether the change was due to the
feedback, treatment as usual or the combination of both
[56]. The SFSS study used young person, parent and
clinician reporters and this information was fed back
to clinician, but the study did not specify if this infor-
mation was fed back to the young person. Feedback
was found to improve client change, and this was
heightened when feedback came from multiple
sources [12]. Multiple feedback sources can provide
different change perspectives of value to the clinician
and young person client [46].
Of special note, the study using the SDQ within a
feedback monitoring system showed that the measure
had to be modified to be used in this way [56]. This sug-
gests the possibility of other measures being modified or
adapted to be used routinely. There are, however, several
barriers to routine feedback, which may account for the
small number of measures identified here [2, 71]. These
include constraints around time, resources and training
needed, and perceived lack of clinical utility [72]. There
are likely to be additional barriers for young people as
clients, as they are a unique client group with higher
dropout rates, are often referred by parents or teachers
rather than being self-referred, and have different goals
for therapy and therapeutic expectations compared with
adults [20].
Limitations
A thorough search strategy was employed in this system-
atic review and it identified a large number of outcome
measures and studies, but it is possible that relevant
measures were missed. Notably, article authors were not
contacted for additional information and the method-
ology excluded articles that were not written in English,
meaning measures used specifically in other cultures
were excluded. The eligibility criteria also excluded arti-
cles pertaining to participants with other health condi-
tions, including substance use and situational stressors.
This was done partly to make the review more manage-
able, but may have excluded relevant measures. Only
two databases were used in the search strategy, MED-
LINE and PsychINFO, although these are the most com-
monly used in systematic reviews of mental health
outcome measures [22, 45, 73]. Together, the databased
yielded an initial 11920 articles, which was filtered to a
comprehensive 184 studies, identifying 29 outcome mea-
sures. Nevertheless, some measures, especially those not
often used for research purposes and primarily used in
clinical practice, may have been missed.
In particular, some popular outcome measures were
not identified via the final criteria, including the Depres-
sion Anxiety Stress Scale (DASS) and the Outcome
Rating Scale (ORS). The DASS is a self-report measure
which comes in a 21 or 42-item version [74]. It is com-
monly used as individual scores for depression, anxiety
and stress and, therefore, was excluded as measuring
specific mental health conditions. The ORS is an outcome
measure developed as a brief alternative to the Outcome
Questionnaire 45.2 (OQ-45.2) [75]. The Y-OQ, which was
included in this review, also comes from the same family
of measures. There is a growing body of research around
the ORS, particularly regarding its use as a feedback
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monitoring system for clinicians [76]. However, in this
review, it was excluded as it was unique to only one study
with young people aged 12 to 25 years [77].
Conclusions
Mental health outcome measures are essential for qual-
ity assurance and monitoring the effectiveness of ser-
vices, and for tracking longitudinal health trends across
time [5, 6]. Although this review identified a large num-
ber of measures used with young people aged 12 to
25 years, only eight were used across this whole age
range, each with strengths and weaknesses. Overall, the
review found no measures designed specifically for
young people. There is a growing push for outcome
measures to be routinely used as feedback monitoring
systems, and to determine clinically meaningful change
[7, 20]. Only two measures were identified here as being
used in this way and this is an area of particular research
need for youth mental health because of the potential
for such an approach to benefit clients [12]. Future re-
search should focus on development of mental health
outcome measures designed specifically for young
people aged 12 to 25 years to accompany changes in
mental health services that target this age range. The
measures should be sensitive to reliable and possibly
clinically significant change that is meaningful to young
people, and also suitable for routine use as feedback to
clinicians and young people themselves. This will pro-
vide services with age-appropriate measures with better
clinical utility and comparative usefulness to drive deliv-
ery of the better mental health outcomes for young
people, who have such a heightened need for early and
effective mental health care.
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